Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
In Vivo (Athens, Greece)
|
April 30, 2024
Neuroendocrine Breast Tumors: Could Multigene Assays Help in Guiding Treatment Decisions? Case Presentation
Christos Markopoulos, Nikolaos Tsoulos, Konstantinos Agiannitopoulos, et al.
World Journal of Gastrointestinal Oncology
|
November 30, 2016
Molecular predictive markers in tumors of the gastrointestinal tract
Eirini Papadopoulou, Vasiliki Metaxa-Mariatou, Georgios Tsaousis, et al.
In Vivo (Athens, Greece)
|
June 27, 2024
Germline Co-deletion of <i>CDKN2A</i> and <i>CDKN2B</i> Genes in Pleomorphic Xanthoastrocytoma: Case Report
Konstantinos Agiannitopoulos, Anastasia Katseli, Kevisa Potska, et al.
Diagnostics (Basel, Switzerland)
|
August 29, 2024
Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation
Nikolaos Tsoulos, Eirini Papadopoulou, Konstantinos Agiannitopoulos, et al.
Oncology Reports
|
November 14, 2017
Tumor molecular profiling of NSCLC patients using next generation sequencing
Nikolaos Tsoulos, Eirini Papadopoulou, Vasiliki Metaxa-Mariatou, et al.
Oncology Letters
|
December 2, 2015
Determination of <i>EGFR</i> and <i>KRAS</i> mutational status in Greek non-small-cell lung cancer patients
Eirini Papadopoulou, Nikolaos Tsoulos, Angeliki Tsirigoti, et al.
BMC Medical Genomics
|
April 15, 2021
Comprehensive tumor molecular profile analysis in clinical practice
Mustafa Özdoğan, Eirini Papadopoulou, Nikolaos Tsoulos, et al.
Plos One
|
December 21, 2019
Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
Eirini Papadopoulou, Nikolaos Tsoulos, Katerina Tsantikidi, et al.
Cancer Genomics & Proteomics
|
December 24, 2021
Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients
Georgios N Tsaousis, Eirini Papadopoulou, Konstantinos Agiannitopoulos, et al.
Cancers
|
November 14, 2023
Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing
Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
In Vivo (Athens, Greece)
|
April 30, 2024
Neuroendocrine Breast Tumors: Could Multigene Assays Help in Guiding Treatment Decisions? Case Presentation
Christos Markopoulos, Nikolaos Tsoulos, Konstantinos Agiannitopoulos, et al.
World Journal of Gastrointestinal Oncology
|
November 30, 2016
Molecular predictive markers in tumors of the gastrointestinal tract
Eirini Papadopoulou, Vasiliki Metaxa-Mariatou, Georgios Tsaousis, et al.
In Vivo (Athens, Greece)
|
June 27, 2024
Germline Co-deletion of <i>CDKN2A</i> and <i>CDKN2B</i> Genes in Pleomorphic Xanthoastrocytoma: Case Report
Konstantinos Agiannitopoulos, Anastasia Katseli, Kevisa Potska, et al.
Diagnostics (Basel, Switzerland)
|
August 29, 2024
Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation
Nikolaos Tsoulos, Eirini Papadopoulou, Konstantinos Agiannitopoulos, et al.
Oncology Reports
|
November 14, 2017
Tumor molecular profiling of NSCLC patients using next generation sequencing
Nikolaos Tsoulos, Eirini Papadopoulou, Vasiliki Metaxa-Mariatou, et al.
Oncology Letters
|
December 2, 2015
Determination of <i>EGFR</i> and <i>KRAS</i> mutational status in Greek non-small-cell lung cancer patients
Eirini Papadopoulou, Nikolaos Tsoulos, Angeliki Tsirigoti, et al.
BMC Medical Genomics
|
April 15, 2021
Comprehensive tumor molecular profile analysis in clinical practice
Mustafa Özdoğan, Eirini Papadopoulou, Nikolaos Tsoulos, et al.
Plos One
|
December 21, 2019
Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
Eirini Papadopoulou, Nikolaos Tsoulos, Katerina Tsantikidi, et al.
Cancer Genomics & Proteomics
|
December 24, 2021
Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients
Georgios N Tsaousis, Eirini Papadopoulou, Konstantinos Agiannitopoulos, et al.
Cancers
|
November 14, 2023
Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing
Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, et al.
Page
of 2